Axonyx Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
3
Axonyx General Information
Description
Operator of a biopharmaceutical company. The company's activities include acquisition and development of proprietary pharmaceutical compounds and new technologies useful in the diagnosis and treatment of Alzheimer's disease, human memory disorders and prion-based illnesses such as Mad Cow Disease.
Contact Information
Website
www.axonyx.comCorporate Office
- 500 Seventh Avenue
- 10th floor
- New York, NY 10018
- United States
Corporate Office
- 500 Seventh Avenue
- 10th floor
- New York, NY 10018
- United States
Axonyx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Axonyx Patents
Axonyx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025521924-A | System for determining battery capacity estimate for implantable device - patents.com | Pending | 08-Jul-2022 | ||
| JP-2025522896-A | System and method for aligning a charger for an implantable medical device - patent application | Pending | 11-May-2022 | ||
| JP-2025516093-A | Device and methods for improved remote programming of implanted neural stimulation systems - patent application | Pending | 04-May-2022 | ||
| JP-2025512425-A | Neurostimulation lead placement systems and methods | Pending | 15-Apr-2022 | ||
| JP-2025501312-A | Header and antenna for neural stimulation device - patent application | Pending | 03-Jan-2022 | A61N1/3754 |
Axonyx Investments & Acquisitions (3)
Axonyx’s most recent deal was a Reverse Merger with TorreyPines Therapeutics. The deal was made on 04-Oct-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TorreyPines Therapeutics | 04-Oct-2006 | Reverse Merger | Drug Discovery | ||
| Oxis International | 18-Jan-2005 | PIPE | Pharmaceuticals | ||
| Oxis International | 20-Jan-2004 | Merger/Acquisition | Pharmaceuticals |
Axonyx Exits (2)
Axonyx’s most recent exit was on 18-Jan-2005 from Oxis International. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Oxis International | 18-Jan-2005 | Completed |
|
||
| Oxis International | 20-Jan-2004 | Merger/Acquisition | Completed |
Axonyx FAQs
-
When was Axonyx founded?
Axonyx was founded in 1997.
-
Where is Axonyx headquartered?
Axonyx is headquartered in New York, NY.
-
What industry is Axonyx in?
Axonyx’s primary industry is Drug Discovery.
-
Is Axonyx a private or public company?
Axonyx is a Private company.
-
What is Axonyx’s current revenue?
The current revenue for Axonyx is .
-
How much funding has Axonyx raised over time?
Axonyx has raised $79.3M.
-
When was Axonyx acquired?
Axonyx was acquired on 04-Oct-2006.
-
Who acquired Axonyx?
Axonyx was acquired by TorreyPines Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
